NextFin News - India's National Stock Exchange, the operator of Asia's most actively traded derivatives market, has cleared the last regulatory hurdle for its initial public offering after a decade-long delay, setting the stage for a listing in the week of September 21 that could value the country's premier bourse at as much as 5.26 trillion rupees ($55 billion). The Securities and Exchange Board of India issued its observation letter on the exchange's draft prospectus on September 4, nearly three months after NSE filed the document on June 17 — the final gate before book-building can begin and, with it, what is poised to become the largest public share sale in Indian history.
The Clearance That Took a Decade
The observation letter ends a listing quest that has been suspended since 2016, when investigations into the exchange's co-location and dark-fibre facilities froze its public-market ambitions and left one of Asia's most valuable financial assets stuck in regulatory limbo. The clearance follows NSE's settlement of past lapses with SEBI, removing the obstacle that had kept the offering on hold for nearly ten years.
The structure of the sale matters as much as the timing. The IPO is entirely an offer for sale — up to 14,89,05,525 equity shares, or nearly 6 percent of NSE's paid-up capital — with no fresh issue. That means NSE itself will receive nothing from the offering; every rupee raised accrues to the selling shareholders. The issue is estimated at around 30,000 crore rupees, which would surpass the 27,870 crore rupees raised by Hyundai Motor India in October 2024 and the 21,000 crore rupees raised by Life Insurance Corporation of India in May 2022, the two largest Indian public offerings to date.
Market sources have indicated book-building could begin on September 11, with the price band likely to be announced around September 15 and a tentative listing date of September 25. Those timelines have not been announced formally and remain subject to the completion of remaining procedural steps.
The seller list reads like a roll call of India's financial establishment. The State Bank of India is the largest selling shareholder, offering up to 2.475 crore shares. Other major sellers include MS Strategic (Mauritius) with up to 1.60 crore shares, the Canada Pension Plan Investment Board with 1.19 crore shares, Aranda Investments (Mauritius) with 1.12 crore shares, Bank of Baroda with around 1.10 crore shares, and the Stock Holding Corporation of India with around 1.09 crore shares. Public-sector insurers — General Insurance Corporation of India, The New India Assurance Company, National Insurance Company and United India Insurance Company — are also participating. Notably, Life Insurance Corporation of India is not part of the share sale.
Unlike most listed Indian companies, NSE operates without an identifiable promoter. Ownership is widely distributed among financial institutions and strategic investors, with no single shareholder exercising controlling influence — a governance structure that removes the promoter discount that typically weighs on Indian listings, but also means there is no anchor shareholder to stabilise the stock in volatile early trading.
The Irony: Earnings That Fell Because the Regulator Did Its Job
Here is the tension at the heart of the listing. The exchange whose IPO SEBI just cleared saw its own earnings decline precisely because SEBI tightened the rules on the business that made NSE rich.
NSE reported total income of 18,713.37 crore rupees for the fiscal year ended March 2026, about 2.4 percent lower than the 19,176.83 crore rupees in FY25. Revenue from operations fell to 16,601.31 crore rupees from 17,140.68 crore rupees. Profit after tax was 10,302.06 crore rupees, down roughly 15 percent from 12,187.69 crore rupees in FY25, with earnings per share slipping to 41.62 rupees from 49.24 rupees. Return on equity stood at 33 percent.
The driver is documented in the regulator's own data. After SEBI introduced measures to curb excessive retail speculation in equity derivatives — higher contract sizes, rationalised weekly expiries, mandatory upfront premium collection and an increase in transaction taxes — options trading volumes in India fell 51 percent during FY26. Retail investors' net losses in the equity derivatives segment fell nearly 18 percent year-on-year to 91,685 crore rupees, and the number of individual investors trading derivatives dropped by about a fifth to 7.86 million.
Yet even after a 15 percent profit decline, NSE converted revenue into profit at a margin of roughly 62 percent, with an EBITDA margin near 67 percent. In the March quarter, the exchange posted consolidated profit after tax of 2,871 crore rupees, up 8 percent year-on-year, on total income of 5,360 crore rupees, up 22 percent — a sequential recovery that suggests the FY26 dip may be a policy-induced trough rather than a structural break.
This is where the cyclical-versus-structural call has to be made explicitly, because getting it wrong flips the entire investment case. The volume shock is cyclical and policy-induced: it was caused by a discrete set of regulatory changes, not by a loss of competitive position, and it will mean-revert as market participants adjust to the new product structure. The moat, by contrast, is structural. NSE has been India's largest exchange by turnover in cash equities and equity derivatives since FY01. It operates the benchmark Nifty 50 index. It runs the country's largest clearing corporation, NSE Clearing, which maintained a Core Settlement Guarantee Fund of 13,079.15 crore rupees as of March 31, 2026. Its investor base grew from around 31 million registered users in March 2020 to more than 129 million by March 2026, and it processes between 12 billion and 14 billion messages a day. Network effects in an exchange are not reversed by a change in contract size.
The distinction matters because it determines what the FY26 numbers represent. If the decline is cyclical, today's earnings are the denominator that tomorrow's recovery will divide into — and a 35-times earnings multiple is an entry ticket to a compounding franchise. If the decline is structural, the multiple is a trap: the earnings base that justifies the price has already shrunk, and the multiple will contract to meet it. The Q4 rebound is the first piece of evidence for the cyclical read, but one quarter is not a trend.
The Valuation: What the Market Is Being Asked to Pay
NSE has marketed its shares to global investors in a range of 2,000 to 2,100 rupees apiece, according to people familiar with the matter, while Indian market reports have cited roadshow expectations as high as 2,500 to 2,800 rupees per share. At the top end of the valuation range — 5.26 trillion rupees, or about $55 billion — the exchange would rank among the world's largest listed exchange operators by market value, behind CME Group and Intercontinental Exchange, which trade at roughly $101 billion and $92.5 billion respectively, and roughly on par with London Stock Exchange Group and Nasdaq, valued at about $57 billion and $49 billion.
At an expected price-to-earnings valuation of around 35 times FY26 earnings, the IPO would sit at a premium to most listed global exchange peers.
Deven Choksey, managing director of fund and wealth manager DRChoksey FinServ, argued the premium is justified:
Post listing, NSE will be top 10 among India's largest companies in terms of market cap, which will garner huge interest from the market. At an expected price-to-earnings valuation of around 35 times, the IPO would provide investors with headroom for gains after listing.
The precedent selling shareholders are underwriting is domestic. Rival Bombay Stock Exchange, which listed on February 3, 2017, has seen its shares surge 28-fold, and its market capitalisation exceeded 1.39 lakh crore rupees in 2026. But that comparison cuts both ways: BSE's multiple expansion came after it was already public and able to reinvest in its platform, whereas NSE's offering brings no fresh capital into the exchange itself. The buyer of NSE shares is purchasing a claim on existing cash flows, not funding the next generation of technology.
There is also a currency dimension to the ambition. A $55 billion listing would place NSE ahead of most Asian exchange operators and make it the most valuable financial-market infrastructure asset ever listed in India — a statement about the depth of domestic savings as much as about the exchange. India's household financial savings have been migrating into equities for half a decade; the IPO is, in effect, the market's first chance to own the tollbooth on that migration.
Second-Order Effects: When the Regulated Becomes the Listed
The first-order story is simple: a monopoly franchise lists at a record valuation. The second-order consequences are less discussed and more consequential.
First, SEBI now occupies a dual role that did not exist before. The regulator whose tightening of derivatives rules directly reduced NSE's FY26 earnings is clearing an IPO whose selling shareholders include public-sector banks and insurers — institutions whose balance sheets are ultimately backstopped by the state. The settlement itself underscores the entanglement: NSE has proposed revised settlement terms of 1,491.21 crore rupees to SEBI in respect of the co-location and dark-fibre matters, and has already recognised a provision of 1,391.21 crore rupees in its FY25-26 accounts. The settlement applications were pending final disposal with SEBI as of the DRHP date; the issuance of the observation letter signals the regulator was satisfied enough on the governance and legal front to let the IPO proceed. When the referee's decisions move the revenue of an asset owned by the referee's own regulated institutions, every future regulatory decision carries a distributional footprint.
Second, the timing collides with a crowded primary market. India's IPO pipeline is gearing up for a strong September, with reports of a record six issues lining up on a single day as companies hasten fundraising plans after a sluggish start to 2026. A 30,000 crore rupee offering of this size competes for the same domestic liquidity as the rest of the calendar. It was unclear whether NSE hitting the market at such a time would add to the pressure or reduce it, said Arun Kejriwal, founder of Kejriwal Research and Investment Services.
Third, there is an expectation gap embedded in the valuation. Investors are being asked to pay 35 times earnings for "India's financialisation story" — the run from 31 million to 129 million registered investors, the 20.33 lakh crore rupees of fund mobilisation through the exchange in FY26 — while the near-term earnings engine that funded that growth, retail equity derivatives, has been deliberately downsized by the regulator. The market is pricing a long-term structural runway on top of a short-term earnings base that has just been shrunk by policy. Those two facts can coexist, but they do not compound at the same rate.
Fourth, the offer-for-sale structure creates a one-way information asymmetry. The sellers — banks, pension funds, insurers — are institutions with the best possible view of the exchange's books, and they are choosing to sell. That is not inherently bearish: these are portfolio rebalancing decisions by institutions that have held the stock for years, and CPPIB and Aranda are simply realising a long-held emerging-market infrastructure investment. But it does mean the marginal buyer at listing is a new shareholder, not an insider, and the price discovery happens in public rather than in the unlisted market where the $55 billion figure was formed.
The Counter-Thesis
The strongest case against the listing is not that NSE lacks a moat — it plainly has one. It is that the price assumes the moat will keep generating monopoly-grade returns while the revenue mix that produced those returns has been permanently altered.
A buyer at 35 times FY26 earnings is paying for a company whose profit fell 15 percent in the year before listing, whose options volumes fell 51 percent, and whose offering puts no fresh capital into the business for technology or capacity investment. The derivatives curbs may not be a cyclical trough at all; they may be a permanent repricing of what a socially acceptable derivatives market looks like in India, in which case the FY26 numbers are not the bottom but the new normal. And in a September crowded with issuers, a 30,000 crore rupee offer-for-sale risks being absorbed only at a discount — a weak debut would set the tone for the stock's entire first year.
This counter-thesis has teeth because it is backed by the regulator's own data on participation decline, not by bearish commentary alone. The answer to it rests on diversification: NSE's revenue spans transaction charges, listing fees, market data services and clearing, and the March-quarter rebound shows the franchise can grow even inside a tighter derivatives regime. But that answer is a claim, not a fact, and it needs a test.
The falsifying signal is specific: if options turnover fails to stabilise or grow within two quarters of listing while NSE's profit after tax growth remains negative, the "cyclical trough" call is wrong and the structural-moat thesis should be discarded. A second signal would be a subscription rate materially below the rest of the September cohort — that would indicate the market is discounting the crowded-calendar risk, not the franchise.
What Comes Next
The near-term path is now procedural. Watch the final price band, expected around September 15, the subscription multiple when book-building opens, and the grey-market premium as a sentiment read. The medium-term path is fundamental: whether derivatives volumes stabilise and whether SEBI's next round of measures tightens or eases. The long-term path is structural: India's capital-markets penetration remains low compared with other major economies, and the runway from 129 million registered investors toward a population of 1.4 billion is the argument that underwrites the premium.
Scenarios split cleanly by horizon. In the base case, NSE lists at a modest premium on scarcity value and then trades in line with global exchange peers over the following twelve months as FY26 earnings are digested. In the upside case, derivatives volumes recover faster than expected and financialisation accelerates, re-rating the stock toward London Stock Exchange Group and Nasdaq multiples. In the downside case, a prolonged derivatives winter combines with a crowded issuance calendar to compress the multiple toward 25 times earnings.
The exchange that spent a decade settling with its regulator is about to ask the market to price it like one that never had anything to apologise for. Whether that price holds depends less on the moat — which is real — than on whether the regulator who just cleared the listing lets the earnings engine run hot enough to justify it.
Explore more exclusive insights at nextfin.ai.
